Answers are grounded in this paper and cite their sources.
In their article assessing long-term volume retention of fat grafting for breast augmentation using magnetic resonance imaging, Ørholt and colleagues found that volumetric steady states were typically reached by 8 months, with an average volume retention of 46%.1 Over the subsequent 3-year postoperative period, they observed that changes in body mass index (BMI) significantly influenced volume retention: a BMI decrease of 1 point was associated with a 22% reduction in retained volume, whereas increases of 1 to 2 points correlated with volume gains of 57% and 85%, respectively. The authors also explored patient-reported outcomes through the BREAST-Q, noting enhanced postoperative satisfaction with both breast appearance and sexual well-being, although satisfaction was not directly linked to the amount of fat graft volume retained. In addition, they found that an increasing graft-to-recipient volume ratio (the ratio of injected fat volume to preoperative breast volume) was associated with a greater percentage augmentation, with no observed plateau in this relationship even at ratios as high as 2:1. Weight loss has been linked to reductions in adipocyte volume, leading to a subsequent decrease in graft volume retention.2,3 This relationship could help explain the clinical findings of BMI-related variations in fat graft volume retention observed in this study. Notably, the relative percentage increase in fat graft retention with a BMI gain (57% for a 1-point increase) is more than double that seen with a BMI decrease (22% for a 1-point drop), highlighting an area ripe for further investigation. In a recent study by Utsunomiya et al. examining factors influencing fat graft volume retention in breast augmentation, preoperative breast volume was identified as the most significant determinant.4 Specifically, they found that for every 100-cc increase in breast volume, volume retention improved by 4% to 8%. The authors attributed this finding to the capacity of larger breasts to hold more grafted fat and provide a more substantial vascular wound bed, enhancing graft retention. Future studies with larger sample sizes could control for preoperative breast volume to better isolate the effects of BMI changes on graft retention. In addition, longitudinally tracking individual patient breast volume and BMI changes while distinguishing volumetric changes attributable to fat grafting would further clarify our understanding of fat graft retention dynamics. This study also demonstrated significantly increased BREAST-Q scores in satisfaction with breast appearance and sexual well-being, although these improvements showed no correlation with fat graft volume retention. Previous research has similarly reported higher BREAST-Q scores following both fat grafting and breast augmentation.5,6 Although this study does not directly address the clinical implications of differing fat graft retention percentages, it raises an important point: the lack of correlation suggests that achieving the desired breast shape and contour may be more clinically meaningful to patients than the exact volume retention percentage. Meeting patients’ aesthetic goals may, therefore, hinge more on overall breast contour than on the precise amount of retained graft. A more detailed characterization of fat graft quality before injection, and an understanding of complications associated with higher fat graft-to-recipient volume ratios (approaching 2:1), would be valuable for other surgeons using these techniques. In the current study, the authors reported no instances of fat necrosis or oil cyst formation during clinical examinations; however, imaging was not used to assess these complications. Their fat grafting technique involves sedimentation and a 14-gauge cannula, which may introduce a higher water content to the graft compared with other processing methods. This suggests that both the relative volume of injected fat to the recipient wound bed and the quality of the fat graft itself could influence retention quality and the likelihood of complications such as fat necrosis and oil cysts. A recent systematic review by Seth et al. on autologous fat grafting for breast augmentation (involving 35 studies and 3757 women) reported an overall complication rate of 27.8%, with fat necrosis comprising 43.7% of all complications.7 The average fat volume injected in these cases was 300 cc, with an average volume retention of 58% (range, 44% to 83%),7 similar to the current study’s findings. Volume retention was found to increase when fat was supplemented with platelet-rich plasma and stromal vascular fraction. Further research exploring various fat processing methods, lipoaspirate washing techniques, and supplementation with platelet-rich plasma and stromal vascular fraction could help refine approaches to improve volume retention in breast augmentation. The authors of this study deserve recognition for contributing valuable insights to the literature on fat graft volume retention in breast augmentation. Their use of magnetic resonance imaging and patient-reported outcomes offers a detailed perspective on how fat graft volume retention varies with BMI changes and impacts patient satisfaction. Future studies with larger patient cohorts will be essential to further explore the relationship between BMI fluctuations, fat graft processing methods, and long-term outcomes in fat graft retention for breast augmentation. DISCLOSURE The authors have no financial interest in any of the drugs, products, or devices mentioned in this Discussion or in the associated article.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: